These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7824894)

  • 1. Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A.
    Yamada T; Liepnieks JJ; Kluve-Beckerman B; Benson MD
    Scand J Immunol; 1995 Jan; 41(1):94-7. PubMed ID: 7824894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin D activity protects against development of type AA amyloid fibrils.
    van der Hilst JC; Kluve-Beckerman B; van der Meer JW; Simon A
    Eur J Clin Invest; 2009 May; 39(5):412-6. PubMed ID: 19740371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation.
    Yamada T; Kluve-Beckerman B; Liepnieks JJ; Benson MD
    Scand J Immunol; 1995 Jun; 41(6):570-4. PubMed ID: 7770727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of AA76, a Common Form of Amyloid A Protein, as a Way of Diagnosing AA Amyloidosis.
    Sato J; Okuda Y; Kuroda T; Yamada T
    Ann Clin Lab Sci; 2016; 46(2):147-53. PubMed ID: 27098620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
    Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
    Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C.
    Buttle DJ; Abrahamson M; Burnett D; Mort JS; Barrett AJ; Dando PM; Hill SL
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):325-31. PubMed ID: 1710889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationship between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis.
    Phipps-Yonas H; Pinard G; Ali-Khan Z
    Scand J Immunol; 2004 Feb; 59(2):168-76. PubMed ID: 14871293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
    Liepnieks JJ; Kluve-Beckerman B; Benson MD
    Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis.
    Röcken C; Fändrich M; Stix B; Tannert A; Hortschansky P; Reinheckel T; Saftig P; Kähne T; Menard R; Ancsin JB; Bühling F
    J Pathol; 2006 Dec; 210(4):478-87. PubMed ID: 17068745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of amyloid proteins by different serine proteases.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Oct; 14(4):389-96. PubMed ID: 6461061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.
    Gardi C; Cavarra E; Calzoni P; Marcolongo P; de Santi M; Martorana PA; Lungarella G
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):237-45. PubMed ID: 8166647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.
    Hol PR; van Ederen AM; Snel FW; Langeveld JP; Veerkamp JH; Gruys E
    Br J Exp Pathol; 1985 Jun; 66(3):279-92. PubMed ID: 2860918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease.
    Mackay EA; Ehrhard A; Moniatte M; Guenet C; Tardif C; Tarnus C; Sorokine O; Heintzelmann B; Nay C; Remy JM; Higaki J; Van Dorsselaer A; Wagner J; Danzin C; Mamont P
    Eur J Biochem; 1997 Mar; 244(2):414-25. PubMed ID: 9119007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition.
    Hwang SR; Stoka V; Turk V; Hook VY
    Biochemistry; 2005 May; 44(21):7757-67. PubMed ID: 15909990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.
    Evin G; Cappai R; Li QX; Culvenor JG; Small DH; Beyreuther K; Masters CL
    Biochemistry; 1995 Oct; 34(43):14185-92. PubMed ID: 7578016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.
    Meek RL; Hoffman JS; Benditt EP
    J Exp Med; 1986 Mar; 163(3):499-510. PubMed ID: 3950541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.
    Patel H; Bramall J; Waters H; De Beer MC; Woo P
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):1041-9. PubMed ID: 8836154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Metalloproteinase-9-Generated COOH-, but Not NH
    Gouwy M; De Buck M; Abouelasrar Salama S; Vandooren J; Knoops S; Pörtner N; Vanbrabant L; Berghmans N; Opdenakker G; Proost P; Van Damme J; Struyf S
    Front Immunol; 2018; 9():1081. PubMed ID: 29915572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
    Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
    J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.